Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?

doi:10.1016/S2213-2600(20)30314-3

. 2020 Sep;8(9):846-847.

doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.

Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?

Dan V Nicolau¹, Mona Bafadhel²

Affiliations

¹ School of Mathematical Sciences, Queensland University of Technology, Brisbane, QLD, Australia; Department of Respiratory Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, UK.
² Department of Respiratory Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, UK. Electronic address: mona.bafadhel@ndm.ox.ac.uk.

PMID: 32738928
PMCID: PMC7392554
DOI: 10.1016/S2213-2600(20)30314-3

Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?

Dan V Nicolau et al. Lancet Respir Med. 2020 Sep.

. 2020 Sep;8(9):846-847.

doi: 10.1016/S2213-2600(20)30314-3. Epub 2020 Jul 30.

Authors

Dan V Nicolau¹, Mona Bafadhel²

Affiliations

¹ School of Mathematical Sciences, Queensland University of Technology, Brisbane, QLD, Australia; Department of Respiratory Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, UK.
² Department of Respiratory Medicine, Nuffield Department of Clinical Medicine, University of Oxford, Oxford OX3 7FZ, UK. Electronic address: mona.bafadhel@ndm.ox.ac.uk.

PMID: 32738928
PMCID: PMC7392554
DOI: 10.1016/S2213-2600(20)30314-3

No abstract available

PubMed Disclaimer

Figures

See this image and copyright information in PMC

Cited by

The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy.
Wang Y, Wu M, Li Y, Yuen HH, He ML. Wang Y, et al. J Biomed Sci. 2022 May 3;29(1):27. doi: 10.1186/s12929-022-00811-4. J Biomed Sci. 2022. PMID: 35505345 Free PMC article. Review.
A review on function and side effects of systemic corticosteroids used in high-grade COVID-19 to prevent cytokine storms.
Langarizadeh MA, Ranjbar Tavakoli M, Abiri A, Ghasempour A, Rezaei M, Ameri A. Langarizadeh MA, et al. EXCLI J. 2021 Feb 15;20:339-365. doi: 10.17179/excli2020-3196. eCollection 2021. EXCLI J. 2021. PMID: 33746666 Free PMC article. Review.
Infection, inflammation and intervention: mechanistic modelling of epithelial cells in COVID-19.
Fadai NT, Sachak-Patwa R, Byrne HM, Maini PK, Bafadhel M, Nicolau DV Jr. Fadai NT, et al. J R Soc Interface. 2021 Feb;18(175):20200950. doi: 10.1098/rsif.2020.0950. Epub 2021 Feb 17. J R Soc Interface. 2021. PMID: 33593209 Free PMC article.
The impact of the first COVID-19 surge on severe asthma patients in the UK. Which is worse: the virus or the lockdown?
Smith SJ, Busby J, Heaney LG, Pfeffer PE, Jackson DJ, Yang F, Fowler SJ, Menzies-Gow A, Idris E, Brown T, Gore R, Faruqi S, Dennison P, Dodd JW, Doe S, Mansur AH, Priyadarshi R, Holmes J, Hearn A, Al-Aqqad H, Loewenthal L, Cooper A, Fox L, Selvan M, Crooks MG, Thompson A, Higbee D, Fawdon M, Nathwani V, Holmes L, Chaudhuri R. Smith SJ, et al. ERJ Open Res. 2021 Feb 1;7(1):00768-2020. doi: 10.1183/23120541.00768-2020. eCollection 2021 Jan. ERJ Open Res. 2021. PMID: 33564672 Free PMC article.
Corticosteroids: A boon or bane for COVID-19 patients?
Sen S, Singh B, Biswas G. Sen S, et al. Steroids. 2022 Dec;188:109102. doi: 10.1016/j.steroids.2022.109102. Epub 2022 Aug 24. Steroids. 2022. PMID: 36029810 Free PMC article. Review.

See all "Cited by" articles

References

1. Fadel R, Morrison AR, Vahia A. Early short course corticosteroids in hospitalized patients with COVID-19. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa60. published online May 19. - DOI - PMC - PubMed
1. Li X, Xu S, Yu M. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146:110–118. - PMC - PubMed
1. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395:473–475. - PMC - PubMed
1. WHO . World Health Organization; Geneva: 2020. Clinical management of severe acute respiratory infection (SARI)when COVID-19 disease is suspected: interim guidance, 13 March 2020.https://apps.who.int/iris/handle/10665/331446
1. The RECOVERY Collaborative Group Dexamethasone in hospitalized patients with COVID-19—preliminary report. N Engl J Med. 2020 doi: 10.1056/NEJMoa2021436. published online July 17. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Associated data

Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov
Actions
- Search in PubMed
- Search in ClinicalTrials.gov

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information

[1] Fadel R, Morrison AR, Vahia A. Early short course corticosteroids in hospitalized patients with COVID-19. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa60. published online May 19. - DOI - PMC - PubMed

[2] Fadel R, Morrison AR, Vahia A. Early short course corticosteroids in hospitalized patients with COVID-19. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa60. published online May 19. - DOI - PMC - PubMed

[3] Li X, Xu S, Yu M. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146:110–118. - PMC - PubMed

[4] Li X, Xu S, Yu M. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146:110–118. - PMC - PubMed

[5] Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395:473–475. - PMC - PubMed

[6] Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet. 2020;395:473–475. - PMC - PubMed

[7] WHO . World Health Organization; Geneva: 2020. Clinical management of severe acute respiratory infection (SARI)when COVID-19 disease is suspected: interim guidance, 13 March 2020.https://apps.who.int/iris/handle/10665/331446

[8] WHO . World Health Organization; Geneva: 2020. Clinical management of severe acute respiratory infection (SARI)when COVID-19 disease is suspected: interim guidance, 13 March 2020.https://apps.who.int/iris/handle/10665/331446

[9] The RECOVERY Collaborative Group Dexamethasone in hospitalized patients with COVID-19—preliminary report. N Engl J Med. 2020 doi: 10.1056/NEJMoa2021436. published online July 17. - DOI - PMC - PubMed

[10] The RECOVERY Collaborative Group Dexamethasone in hospitalized patients with COVID-19—preliminary report. N Engl J Med. 2020 doi: 10.1056/NEJMoa2021436. published online July 17. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?

Affiliations

Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?

Authors

Affiliations

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Associated data

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical